Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation.

CONTEXT Inactivating mutations of SDHD, which is mapped to 11q23 and encodes the cybS subunit of succinate dehydrogenase, predispose to hereditary paraganglioma (PGL) and/or pheochromocytoma. So far no disease was shown to occur in case of maternal transmission of a SDHD mutation, suggesting the existence of genomic imprinting. A hypothetic model, involving the loss of the maternal copy of a tumor suppressor gene mapped to 11p15 in the tumoral tissue, has been proposed to explain this mode of inheritance. OBJECTIVE Our objective was to investigate the possibility of maternal transmission of SDHD-linked PGL. DESIGN A three-generation family carrying the SDHD W43X mutation was studied at the clinical, pathological, and genetical levels. RESULTS The germline's mutation was probably inherited from the grandfather. In the second generation, three carriers (two females and one male), who had the same at risk 11q13-q23 haplotype, developed multiple cervical PGLs. In the third generation, one boy received the mutation from his mother and developed a glomus tympanicum PGL at 11 yr. He shared only the 11q23 haplotype with the other affected members of the family. Methylation analysis of the differentially methylated region upstream of the maternally expressed H19 gene, mapped to 11p15, showed that the seventh CTCF binding site is hypermethylated in the germline of the affected boy suggesting a gain of imprinting. CONCLUSION Our data show that maternal transmission of a SDHD-linked PGL, even if a rare event, can occur. Therefore, we propose that children who inherited a pathogenic mutation from their mother should be considered as at risk of PGL.

[1]  M. Perrais,et al.  Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells , 2007, Oncogene.

[2]  M. Negrini,et al.  Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. , 2007, Human molecular genetics.

[3]  A. Gabory,et al.  The H19 gene: regulation and function of a non-coding RNA , 2006, Cytogenetic and Genome Research.

[4]  P. Dahia Evolving concepts in pheochromocytoma and paraganglioma , 2006, Current opinion in oncology.

[5]  M. Mascalchi,et al.  Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X , 2005, Journal of Medical Genetics.

[6]  H. Spencer,et al.  A census of mammalian imprinting. , 2005, Trends in genetics : TIG.

[7]  B. Baysal Genomic imprinting and environment in hereditary paraganglioma , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.

[8]  Maria Vernucci,et al.  Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome , 2004, Nature Genetics.

[9]  E. Jordanova,et al.  Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families , 2004, Oncogene.

[10]  K. Sotlar,et al.  Chromosome 11 monosomy in conjunction with a mutated SDHD initiation codon in nonfamilial paraganglioma cases. , 2004, Cancer genetics and cytogenetics.

[11]  M. Fraga,et al.  Genetic and epigenetic profile of sporadic pheochromocytomas , 2004, Journal of Medical Genetics.

[12]  B. Baysal On the association of succinate dehydrogenase mutations with hereditary paraganglioma , 2003, Trends in Endocrinology & Metabolism.

[13]  C. Aston,et al.  Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect , 2003, Human Genetics.

[14]  E. Leteurtre,et al.  Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes , 2003, Journal of medical genetics.

[15]  J. Benítez,et al.  Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma , 2002, European Journal of Human Genetics.

[16]  W. Rubinstein,et al.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas , 2002, Journal of medical genetics.

[17]  P. Rustin,et al.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.

[18]  C. Eng,et al.  Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. , 2000, Cancer research.

[19]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[20]  P. Heikkilä,et al.  Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells. , 1997, The Journal of clinical endocrinology and metabolism.

[21]  P. Maaswinkel-Mooy,et al.  GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY , 1989, The Lancet.